Ocular Therapeutix OCUL Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Ocular Therapeutix’s reported figures.
Based on trailing twelve months.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's return on equity?
- Ocular Therapeutix (OCUL) reported return on equity of -68.6% in Q1 2026.
- How has Ocular Therapeutix's return on equity changed year-over-year?
- Ocular Therapeutix's return on equity decreased by 19.9% year-over-year, from -57.2% to -68.6%.
- What is the long-term trend for Ocular Therapeutix's return on equity?
- Over 4 years (2021 to 2025), Ocular Therapeutix's return on equity has grown at a 61.9% compound annual growth rate (CAGR), from -8% to -54.9%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.